For SJW, open label data and “post marketing” surveillance data in depressed pediatric patients exist. For SAM-e, only a case series summarizing experience in three depressed pediatric patients was identified.
Despite the paucity of data supporting their use in children and adolescents, both products are widely utilized in these populations, particularly SJW.
In Germany, SJW is labeled for adolescent use and is the most commonly used antidepressant in that population